Every donation fuels groundbreaking research and provides vital patient support programs to help more people survive cancer.
The value must be greater than or equal to $5
The value must be lesser than $1M
Your gift is 100% tax deductible.
Espa?ol
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Live Chat available weekdays, 7:00 am - 6:30 pm CT
Call us at 1-800-227-2345
Available any time of day or night
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
People with Peutz-Jeghers syndrome have polyps in their digestive tract and in a few other places.
Peutz-Jeghers syndrome (PJS) is an inherited condition that causes abnormal growths, called polyps, in the gastrointestinal (GI) tract and other places in the body. Having PJS increases a person’s risk of developing a few types of cancer.
People with Peutz-Jeghers syndrome (PJS) are more likely to have polyps, or abnormal growths, in their GI tract. These are most often found in the small bowel and also can be found in the stomach or large bowel (colon). People with PJS tend to develop symptoms from these polyps between the ages of 10 and 30. Symptoms can include:
Polyps can grow in other places in people with PJS, as well. Polyps may be found in the kidneys, bladder, lungs, or nose and throat area.
People with this condition also often have skin changes that look like freckles in unusual places. These small dark spots can be found:
These spots often appear in the first two years of life, increasing in size and number until the person goes through puberty and then they may fade and become less visible over time.
Most Peutz-Jeghers syndrome (PJS) is caused by a change in the STK11 (LKB1) gene. The STK11 gene is a tumor suppressor gene. This means a normal STK11 gene controls the growth and division of cells in the body. When the gene is changed or mutated, the cells grow unchecked, leading to polyps and cancer.
Peutz-Jeghers syndrome (PJS) is a rare condition that affects males and females equally. It is estimated to affect 1 in 50,000 to 200,000 people.
Because only some people with Peutz-Jeghers syndrome (PJS) have STK11 gene mutations, the diagnosis is based on clinical findings and symptoms. A clinical diagnosis can be made when:
Gene testing is usually recommended for a person with a clinical diagnosis of PJS. A change in the STK11 gene confirms a diagnosis and can be important for counseling and deciding if others in the family should get testing.
The absence of a change in the STK11 gene does not rule out PJS in a person who meets the other clinical diagnosis criteria. People without STK11 gene changes but with clinical signs and symptoms of the condition are treated the same as those with PJS-related gene changes.
Peutz-Jeghers syndrome (PJS) is associated with an increased risk of several cancers. It is estimated that 37% to 93% of people diagnosed with PJS will have at least one cancer during their life.
People with PJS have a higher risk of gastrointestinal cancers, such as colorectal cancer, stomach cancer, and small bowel cancer. PJS also increases the risk of:
Early detection testing can find or offer opportunities to prevent some types of cancer in people with PJS.
There is no cure for PJS, however regular cancer early detection tests can look for and remove polyps before they become cancer or find cancer earlier when treatment is more likely to be successful.
Anyone with PJS should have a routine physical exam once a year with blood counts to detect low iron from blood loss.
Because people with PJS have a higher risk of some types of cancer, screening tests also are recommended.
Gastrointestinal (GI) cancer screening with endoscopy, colonoscopy, and visualization of the small bowel (either video capsule endoscopy or CT/MRI enterography) should start between the ages of 8 and 10. How often screening should be done after the first test depends on:
People with PJS are at higher risk for developing other types of cancer. Screening can be done for some of these cancers with regular physical exams or other tests.
Testing if you have a family member with PJS
First-degree relatives (such as siblings or children) of someone with PJS should have a physical exam once a year, paying attention to signs of PJS-like skin changes or early puberty. First-degree relatives may be offered genetic testing if they have not received a clear diagnosis before the age of 8.
Polyps larger than 0.5 cm, or those that are causing symptoms, should be removed either during an endoscopy or colonoscopy or surgically, whenever possible to evaluate them for and prevent cancer. Colectomy, a procedure to remove part of the intestine, is sometimes needed if there are too many polyps present or changes suspicious for cancer have been found.
If cancer is found, it is treated the same as cancer in a person without PJS. The goal of regular testing is to prevent cancer or detect it early, when treatment might be more successful.
Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
Beggs AD, Latchford AR, Vasen HF, Moslein G, Alonso A, Aretz S, et al. Peutz-Jeghers syndrome: a systematic review and recommendations for management. Gut. 2010;59(7):975-986.
Boland CR, Idos GE, Durno C, Giardiello FM, Anderson JC, Burke CA, et al. Diagnosis and Management of Cancer Risk in the Gastrointestinal Hamartomatous Polyposis Syndromes: Recommendations From the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2022;162(7):2063-2085.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric. v.1.2025 – June 13, 2025. Accessed at https://www.nccn.org/professionals/physician_gls/pdf/genetics_ceg.pdf on August 25, 2025.
Sherman S, Menon G, Krishnamurthy K. Peutz-Jeghers Syndrome. [Updated 2025 Feb 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK535357/
Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW. ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol. 2015;110(2):223-263.
Tacheci I, Kopacova M, Bures J. Peutz-Jeghers syndrome. Curr Opin Gastroenterol. 2021;37(3):245-254.
Last Revised: September 11, 2025
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.
Help us end cancer as we know it, for everyone.